GO:0060315 negative regulation of ryanodine-sensitive calcium-release channel activity: Calcium Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060315 describes any biological process that decreases the activity of ryanodine-sensitive calcium-release channels (RyRs), which are intracellular calcium channels opened by ryanodine-class ligands.
• RyR-mediated calcium release is essential for excitation-contraction coupling in cardiac, skeletal, and smooth muscle, as well as for oocyte maturation and nuclear calcium signaling.
• Negative regulation of RyR activity prevents excessive cytosolic calcium, which would otherwise trigger arrhythmias, cell death, or impaired arterial tone.
• Key proteins involved include RyR isoforms (RYR1, RYR2, RYR3), calmodulin, FKBP12/12.6, and calcium-dependent kinases/phosphatases that modulate channel open probability.
• Dysregulation of RyR negative regulation is linked to cardiac arrhythmias, heart failure, and cerebral artery dysfunction.
• CRISPR-based knockout, point-mutation, and knock-in models enable precise dissection of RyR regulatory mechanisms in disease-relevant cell types.
Description
The ryanodine-sensitive calcium-release channel (RyR) is a large intracellular ion channel that mediates calcium-induced calcium release from the endoplasmic/sarcoplasmic reticulum, a process fundamental to muscle contraction, oocyte maturation, and nuclear calcium signaling. The Gene Ontology term GO:0060315, negative regulation of ryanodine-sensitive calcium-release channel activity, encompasses any process that decreases the open probability or conductance of these channels, thereby fine-tuning calcium transients. This regulatory mechanism is critical because uncontrolled RyR opening can deplete calcium stores and elevate cytosolic calcium to toxic levels, leading to cellular dysfunction. Researchers study this term to understand how cells maintain calcium homeostasis and to identify therapeutic targets for diseases such as cardiac arrhythmias and vascular disorders. The term is defined in QuickGO as any process that decreases the activity of a ryanodine-sensitive calcium-release channel, where the channel catalyzes transmembrane calcium transfer upon binding a ryanodine-class ligand. This article synthesizes published findings on the mechanisms, key genes, and experimental models relevant to GO:0060315, providing a resource for biomedical researchers.
negative regulation of ryanodine-sensitive calcium-release channel activity At A Glance
| GO ID | GO:0060315 |
|---|---|
| GO term | negative regulation of ryanodine-sensitive calcium-release channel activity |
| Ontology | biological_process |
| Synonym | None |
| Major function | Decreases the activity of ryanodine-sensitive calcium-release channels, reducing calcium release from intracellular stores |
| Related cellular component | Sarcoplasmic reticulum, endoplasmic reticulum, nuclear envelope |
| Related molecular function | Calcium channel inhibitor activity, calcium ion binding |
| Associated processes | Excitation-contraction coupling, oocyte maturation, vascular tone regulation |
What Is GO:0060315?
GO:0060315 is a biological process term that refers to any mechanism that reduces the activity of ryanodine-sensitive calcium-release channels. These channels are intracellular calcium channels that open in response to ryanodine or related ligands, allowing calcium ions to flow across membranes. Negative regulation can occur through direct channel modulation, changes in channel expression, or alterations in associated regulatory proteins, ultimately decreasing calcium release from intracellular stores.
Why Is negative regulation of ryanodine-sensitive calcium-release channel activity Important in Cell Biology?
Negative regulation of ryanodine-sensitive calcium-release channel activity is essential for maintaining calcium homeostasis and preventing pathological calcium overload. In cardiac and smooth muscle, excessive RyR opening can cause arrhythmias, heart failure, and altered vascular tone. In oocytes, proper RyR regulation is required for nuclear maturation and successful fertilization. Thus, understanding this process provides insights into fundamental physiology and offers targets for therapeutic intervention in cardiovascular and reproductive disorders.
• Prevents calcium overload that can trigger cardiac arrhythmias and heart failure.
• Regulates arterial diameter and cerebral blood flow via calcium-dependent potassium channels.
• Controls nuclear calcium signals necessary for oocyte maturation.
• Modulates excitation-contraction coupling in skeletal and cardiac muscle.
• Dysregulation is implicated in hypertension and vascular dysfunction.
• Provides targets for pharmacological modulation of RyR channels.
• Essential for proper embryonic development and cardiac precursor cell function.
• Influences gene expression through nuclear calcium signaling.
• Potential therapeutic avenue for preventing calcium-related cell death.
• Key to understanding calcium handling in excitable and non-excitable cells.
What Happens During negative regulation of ryanodine-sensitive calcium-release channel activity?
Initiation of negative regulation
In simple terms: The cell senses too much calcium release and starts to put the brakes on the channel.
Negative regulation of RyR channels can be initiated by various signals, including elevated cytosolic calcium, phosphorylation events, or binding of regulatory proteins such as calmodulin. For example, in cerebral arteries, RyR activity is modulated to maintain arterial diameter via calcium-dependent potassium channels. In oocytes, IP3R, RyR, and L-type calcium channels participate in nuclear maturation, suggesting that negative regulation may be developmentally timed.
Direct channel modulation
In simple terms: Proteins or small molecules bind to the channel and reduce its opening.
Direct modulation involves proteins like FKBP12/12.6, which stabilize the closed state of RyR, and calmodulin, which inhibits RyR activity at high calcium concentrations. Phosphorylation by kinases such as PKA or CaMKII can either activate or inhibit RyR depending on the context. In arterial smooth muscle, RyR-mediated calcium sparks activate calcium-dependent potassium channels, leading to hyperpolarization and vasodilation; negative regulation of RyR would reduce this effect.
Downstream effects on calcium signaling
In simple terms: Less calcium is released, so calcium-dependent processes slow down.
When RyR activity is decreased, cytosolic and nuclear calcium transients are reduced. This affects processes such as muscle contraction, gene transcription, and oocyte maturation. In cardiac precursor cells derived from ES cells, functional characteristics include calcium handling typical of cardiomyocytes, where RyR regulation is critical for proper beating. In Rhinella arenarum oocytes, RyR inhibition may delay nuclear maturation.
Integration with other calcium channels
In simple terms: The cell coordinates RyR with other calcium channels to keep calcium balanced.
Negative regulation of RyR does not occur in isolation; it is integrated with IP3 receptors and L-type calcium channels. In oocytes, all three channel types participate in nuclear maturation, indicating cross-talk. In cerebral arteries, RyR activity is linked to L-type calcium channels and calcium-dependent potassium channels to control vascular tone. Thus, negative regulation of RyR is part of a broader calcium signaling network.
Key Genes Involved in GO:0060315 negative regulation of ryanodine-sensitive calcium-release channel activity
The following genes and proteins are central to the negative regulation of ryanodine-sensitive calcium-release channel activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RYR1 | Skeletal muscle ryanodine receptor; mediates calcium release for contraction | Target for malignant hyperthermia and myopathies |
| RYR2 | Cardiac ryanodine receptor; essential for excitation-contraction coupling | Mutations linked to arrhythmias and heart failure |
| RYR3 | Brain and smooth muscle ryanodine receptor; modulates calcium signaling | Implicated in neuronal plasticity and vascular tone |
| CALM1 | Calmodulin; binds and inhibits RyR at high calcium | Regulates RyR activity in cardiac and smooth muscle |
| FKBP1A | FKBP12; stabilizes RyR closed state | Modulates RyR leak in heart and skeletal muscle |
| FKBP1B | FKBP12.6; cardiac-specific RyR stabilizer | Defects linked to arrhythmias |
| CAMK2A | CaMKII; phosphorylates RyR, affecting open probability | Key regulator in cardiac arrhythmias |
| PRKACA | PKA catalytic subunit; phosphorylates RyR | Modulates RyR during fight-or-flight response |
| PPP1CA | Protein phosphatase 1; dephosphorylates RyR | Counteracts kinase effects on RyR |
| PPP2CA | Protein phosphatase 2A; dephosphorylates RyR | Regulates RyR in heart |
| KCNMA1 | BK channel; activated by RyR-mediated calcium sparks | Links RyR to vascular tone |
| ITPR1 | IP3 receptor; interacts with RyR in calcium signaling | Participates in oocyte maturation |
| CACNA1C | L-type calcium channel; provides trigger calcium for RyR | Essential for excitation-contraction coupling |
| ATP2A2 | SERCA2; refills calcium stores for RyR | Maintains calcium homeostasis |
| CASQ2 | Calsequestrin; calcium buffer in SR | Modulates RyR activity |
| TRDN | Triadin; anchors calsequestrin to RyR | Regulates RyR gating |
| JPH2 | Junctophilin-2; maintains SR-plasma membrane junctions | Required for RyR function |
How Is negative regulation of ryanodine-sensitive calcium-release channel activity Regulated?
The negative regulation of ryanodine-sensitive calcium-release channel activity is itself regulated by multiple signaling pathways. Phosphorylation by PKA and CaMKII can either enhance or reduce RyR activity depending on the site and context. Calmodulin binding inhibits RyR at high calcium concentrations. FKBP12/12.6 stabilizes the closed state, and its dissociation increases channel open probability. In cerebral arteries, RyR activity is modulated by calcium-dependent potassium channels, which provide feedback inhibition. In oocytes, hormonal signals may regulate RyR to control nuclear maturation. Thus, a complex network of kinases, phosphatases, and accessory proteins fine-tunes RyR negative regulation.
negative regulation of ryanodine-sensitive calcium-release channel activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia | Knock-in mouse with RYR2 mutation; hiPSC-derived cardiomyocytes |
| FKBP1B | Heart failure and arrhythmias | Knockout mouse; cardiac-specific overexpression |
| CALM1 | Long QT syndrome and arrhythmias | Point-mutation knock-in in hiPSCs |
| RYR1 | Malignant hyperthermia and myopathies | Knock-in mouse; skeletal muscle cells |
| RYR3 | Vascular dysfunction | Knockout rat; smooth muscle cells |
Cardiac arrhythmias and heart failure
Dysregulated RyR2 activity, often due to impaired negative regulation, leads to diastolic calcium leak, delayed afterdepolarizations, and arrhythmias. Mutations in RYR2 or its regulatory proteins (e.g., FKBP12.6, calmodulin) are linked to catecholaminergic polymorphic ventricular tachycardia and heart failure.
Vascular dysfunction and hypertension
In cerebral arteries, RyR-mediated calcium sparks activate BK channels to cause vasodilation. Negative regulation of RyR is necessary to prevent excessive vasoconstriction. Impaired RyR regulation may contribute to hypertension and altered cerebral blood flow.
Reproductive disorders
In oocytes, RyR, IP3R, and L-type calcium channels participate in nuclear maturation. Disruption of negative regulation could lead to premature or failed maturation, affecting fertility.
Developmental defects
ES cell-derived cardiac precursor cells rely on proper RyR regulation for functional calcium handling. Aberrant negative regulation may impair cardiac development.
From negative regulation of ryanodine-sensitive calcium-release channel activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RYR2 negative regulation cause arrhythmias? | Knockout or point-mutation knock-in in hiPSC-derived cardiomyocytes |
| How does FKBP12.6 stabilize RyR2? | Tagged knock-in for live-cell imaging |
| What is the role of RyR3 in cerebral arteries? | Knockout rat or mouse; pressure myography |
| Does calmodulin binding inhibit RyR1? | Point mutation in CALM1 knock-in mice |
| How does RyR regulation affect oocyte maturation? | Knockdown/knockout in Xenopus or Rhinella oocytes |
| Can overexpression of SERCA rescue RyR leak? | Overexpression of ATP2A2 in cardiac cells |
How to Study the negative regulation of ryanodine-sensitive calcium-release channel activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging | Intracellular calcium concentration | Assessing RyR activity in live cells |
| Patch-clamp | Single-channel currents | Measuring RyR open probability |
| CRISPR knockout | Loss of gene function | Determining necessity of regulators |
| CRISPR knock-in | Introduction of specific mutations | Modeling disease-associated variants |
| Co-immunoprecipitation | Protein-protein interactions | Identifying RyR complex components |
| Phosphoproteomics | Phosphorylation sites | Mapping regulatory phosphorylation |
| RNA-seq | Gene expression changes | Assessing transcriptional regulation |
| Proximity ligation assay | In situ protein interactions | Visualizing RyR-regulator complexes |
Calcium imaging
Fluorescent calcium indicators (e.g., Fluo-4, Fura-2) are used to measure cytosolic and nuclear calcium transients in live cells. This method can assess RyR activity and its negative regulation in response to agonists or genetic manipulation.
Electrophysiology
Patch-clamp and planar lipid bilayer techniques directly measure RyR channel open probability and conductance. These methods are gold-standard for studying negative regulation at the single-channel level.
Genetic manipulation with CRISPR
CRISPR/Cas9 knockout, point mutation, and knock-in models allow precise editing of RYR genes and their regulators. These models are essential for linking specific residues or regulatory sites to channel function.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins associated with RyR complexes under conditions of negative regulation. This reveals novel regulators and post-translational modifications.
How CRISPR Can Be Used to Study GO:0060315 negative regulation of ryanodine-sensitive calcium-release channel activity
Knockout
CRISPR knockout of RYR genes or their regulators (e.g., FKBP1B, CALM1) in cell models can abolish negative regulation, leading to increased calcium leak. These models are used to study the consequences of loss of function in cardiomyocytes, smooth muscle cells, and oocytes.
Point Mutation
Point mutations in RYR2 or CALM1 identified in patients can be introduced via CRISPR to model disease. These models help determine whether specific residues are required for negative regulation and can be used for drug screening.
Knock-in
Knock-in of tagged RyR (e.g., GFP or HA) allows live-cell imaging and proteomic analysis of channel complexes. This approach is valuable for tracking channel localization and interactions under negative regulation.
Overexpression
Overexpression of negative regulators such as FKBP12.6 or calmodulin can suppress RyR activity. This is used to test whether enhancing negative regulation can rescue disease phenotypes in cellular models.
How EDITGENE Supports negative regulation of ryanodine-sensitive calcium-release channel activity Research
Researchers studying negative regulation of ryanodine-sensitive calcium-release channel activity-related genes often need to determine whether a candidate gene is causally involved in channel regulation or disease. EDITGENE provides comprehensive CRISPR services to create precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of ryanodine-sensitive calcium-release channel activity research.
Frequently Asked Questions About negative regulation of ryanodine-sensitive calcium-release channel activity
What is GO:0060315?
GO:0060315 is a Gene Ontology term for any biological process that decreases the activity of ryanodine-sensitive calcium-release channels, which are intracellular calcium channels opened by ryanodine-class ligands.
What genes are involved in negative regulation of ryanodine-sensitive calcium-release channel activity?
Key genes include RYR1, RYR2, RYR3, CALM1, FKBP1A, FKBP1B, CAMK2A, and PPP1CA, among others.
How does negative regulation of RyR affect heart function?
It prevents excessive calcium leak from the sarcoplasmic reticulum, which would otherwise cause arrhythmias and heart failure.
What diseases are linked to impaired RyR negative regulation?
Cardiac arrhythmias, heart failure, hypertension, and reproductive disorders have been associated with dysregulated RyR regulation.
What methods are used to study RyR negative regulation?
Calcium imaging, patch-clamp electrophysiology, CRISPR knockout/knock-in, and proteomics are commonly used.
Can CRISPR be used to model RyR-related diseases?
Yes, CRISPR knockout, point mutation, and knock-in models in cardiomyocytes and other cell types are valuable for studying RyR regulation and disease mechanisms.
What is the role of calmodulin in RyR regulation?
Calmodulin binds to RyR and inhibits its activity at high calcium concentrations, contributing to negative regulation.
How does FKBP12.6 regulate RyR?
FKBP12.6 stabilizes the closed state of RyR2, reducing calcium leak; its dissociation increases channel open probability.
Is RyR negative regulation important in oocytes?
Yes, RyR, IP3R, and L-type calcium channels participate in nuclear maturation of oocytes, and their regulation is critical for proper development.
What EDITGENE services are available for RyR research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for RyR-related genes.
Conclusion
GO:0060315, negative regulation of ryanodine-sensitive calcium-release channel activity, is a critical biological process that maintains calcium homeostasis and prevents pathological calcium overload. Its dysregulation is implicated in cardiac, vascular, and reproductive disorders. Advances in CRISPR-based models and calcium imaging techniques continue to unravel the molecular players and therapeutic potential of targeting RyR negative regulation. EDITGENE provides the tools to accelerate this research through custom cell models and screening services.
References
- 1. Toranzo GS et al.. 2014. Participation of IP3R, RyR and L-type Ca2+ channel in the nuclear maturation of Rhinella arenarum oocytes.. Zygote 22(2):110-23 PMID: 22805181
- 2. Knot HJ et al.. 1998. Ryanodine receptors regulate arterial diameter and wall [Ca2+] in cerebral arteries of rat via Ca2+-dependent K+ channels.. J Physiol 508 ( Pt 1)(Pt 1):211-21 PMID: 9490841
- 3. Kolossov E et al.. 1998. Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein.. J Cell Biol 143(7):2045-56 PMID: 9864374
